Are There Any Safety Concerns or Allergic Reactions Associated with sh-Polypeptide-7 in Topical Hair Products?

Peptides have become increasingly popular in hair care products, especially in treatments claiming to support hair growth, scalp health, and follicle strength. Among these ingredients is sh-Polypeptide-7. Despite the name, it is not a small peptide: the EU cosmetic-ingredient database (CosIng) describes it as recombinant human somatotropin — human growth hormone — made by bacteria carrying a synthetic copy of the human gene. Whether any of it reaches the bloodstream from a scalp product has not been studied, and microneedling or laser treatment before application bypasses the skin barrier. As more consumers encounter this ingredient on shampoo bottles, scalp serums, and hair loss treatments, questions naturally arise about its safety and whether it can cause allergic reactions or other unwanted effects.

This article explains what is and is not known about sh-Polypeptide-7 in topical hair products: how the ingredient is described by its makers, how cosmetic peptides are normally tested, and how thin the published evidence on this particular peptide is. A search of PubMed returns no published human safety or efficacy studies naming sh-Polypeptide-7, so nothing below should be read as a safety verdict for this ingredient.

---

Understanding sh-Polypeptide-7 in Simple Terms

sh-Polypeptide-7 belongs to a group of ingredients called synthetic human peptides. The "sh" stands for "synthetic human," meaning the molecule is produced in laboratories using biotechnology rather than extracted from people or animals. Peptides and proteins are chains of amino acids; sh-Polypeptide-7 is a full-length protein hormone of roughly 190 amino acids, much larger than a typical cosmetic peptide. Proteins and peptides play key roles in the body, including sending signals between cells and helping tissues repair themselves.

In cosmetics and hair care, peptides are often included because suppliers say they can signal skin and hair follicle cells to behave in healthier ways. Some peptides are marketed as encouraging cells to produce more collagen, while others are marketed as supporting blood flow or reducing inflammation. sh-Polypeptide-7 is commonly marketed as a growth-factor-like peptide, meaning suppliers describe it as imitating natural substances in the body that help regulate cell growth and repair.

When applied to the scalp, manufacturers suggest that sh-Polypeptide-7 may support the environment around hair follicles, potentially improving hair strength or growth conditions. These are marketing claims. They are based on how other, better-studied peptides behave in laboratory work, not on published human clinical trials of sh-Polypeptide-7 itself.

Why Safety Questions Matter With Peptide-Based Hair Products

Any ingredient that interacts with human cells, especially one designed to mimic biological signals, naturally raises safety concerns. People worry about skin irritation, allergic reactions, long-term exposure risks, and whether such ingredients might affect the body beyond the scalp.

The skin acts as a barrier. Some small peptides can penetrate its upper layers; sh-Polypeptide-7 is a large protein, and how much of it, if any, crosses the skin has not been measured. Procedures such as microneedling or laser treatment bypass the barrier, and no published study describes the effects or safety of a recombinant growth hormone applied that way. For this reason, cosmetic peptides are usually put through irritation, toxicity and sensitisation testing by the manufacturer before a product is placed on the market. As the regulatory section below explains, that testing is the manufacturer's responsibility rather than a government pre-approval.

Because there is no published literature on sh-Polypeptide-7 specifically, any discussion of its safety is an extrapolation from how similar cosmetic peptides and growth-factor-like compounds behave. Extrapolation is not evidence about this ingredient.

How Cosmetic Peptides Are Normally Tested

Laboratory Cell Studies on Synthetic Peptides

Many peptide ingredients used in cosmetics, including growth-factor-like peptides, undergo laboratory testing using human skin cells grown in dishes. These are called in vitro studies. In these experiments, researchers expose cells to different concentrations of peptides to see if they cause cell death, DNA damage, or abnormal behavior. Cell health is typically evaluated using metabolic activity tests, which measure how well cells function after exposure.

Cosmetic peptides are generally described as showing little toxicity in this kind of work at the concentrations used in finished products, though Tressless has not verified a published source for that for peptides as a class. The limits of the method are well known: laboratory conditions do not reflect real human skin, which has protective layers and an immune system, and they say nothing about long-term exposure, interactions with other cosmetic ingredients, or individual skin sensitivities.

Tressless could not locate a published in vitro study that tested sh-Polypeptide-7 itself, so no result from this category of research can be attributed to it.

---

Animal-Based and Human Skin Testing

Before many cosmetic ingredients reach the market, they are evaluated for irritation and allergic potential. Historically this involved animal models, with the ingredient applied to the skin of rabbits or guinea pigs over days or weeks and reactions scored on standardized irritation scales; animal testing for cosmetics is now banned in the European Union and restricted elsewhere, and validated non-animal methods have largely replaced it.

The most relevant safety assessment for a topical ingredient is human patch testing. In these studies, small amounts of a substance are applied to patches placed on volunteers' skin, usually on the back, and left in place for 24 to 48 hours. Dermatologists then examine the skin for redness, swelling, itching, or blistering. The evaluation method usually combines visual scoring with participant symptom reports.

Two limitations apply to almost all of this work as it relates to hair products. Finished formulations are usually tested rather than isolated peptides, so it is hard to know which ingredient caused any reaction observed; and, again, Tressless found no published patch-test data naming sh-Polypeptide-7.

Specific Evidence Related to sh-Polypeptide-7

At present there are no publicly available peer-reviewed studies focused on sh-Polypeptide-7 as an isolated ingredient. This is common in the cosmetic industry, where many safety evaluations are conducted internally by manufacturers and submitted to regulatory bodies rather than published in scientific journals. It also means outside reviewers cannot check the work. Anyone claiming a safety record for this peptide is relying on unpublished supplier data or on results from other peptides.

Can sh-Polypeptide-7 Cause Allergic Reactions?

Allergic reactions happen when the immune system identifies a substance as harmful and overreacts. Common cosmetic allergies include reactions to fragrances, preservatives, and certain plant extracts. Peptides are often described as low-risk allergens because they resemble substances already present in the human body — but proteins and peptides can and do act as allergens, and "resembles something in the body" is a rationale, not a test result.

Cosmetic peptides as a class are generally described as rarely causing true allergic reactions, with most reported side effects being mild irritation such as redness, itching, or dryness. That description has not been tested for sh-Polypeptide-7. Individual sensitivity can never be ruled out. A person with very sensitive skin or a history of cosmetic allergies could react to almost any ingredient, including peptides like sh-Polypeptide-7.

Dermatologists commonly advise patch testing a new hair or skincare product on a small area before full use, especially for people prone to reactions. If you have a history of cosmetic allergies, eczema, or an existing scalp condition, talk to a doctor or dermatologist before starting a new scalp product, and stop using it and seek advice if a rash, swelling, or persistent irritation develops. Because sh-Polypeptide-7 is a growth-hormone ingredient, people who are pregnant, breastfeeding, or have diabetes, a history of cancer, or any endocrine condition should talk to a doctor or pharmacist before using it.

The Bigger Picture: Regulatory Oversight

In the United States, the Food and Drug Administration (FDA) regulates cosmetic products but does not pre-approve cosmetic ingredients. Manufacturers are legally responsible for ensuring product safety. The FDA monitors adverse event reports and can act if an ingredient is shown to be harmful. In Europe, cosmetic products fall under the EU Cosmetic Regulation, which requires a safety assessment by a qualified assessor before a product reaches the market; a listing in the CosIng inventory is not an approval. US federal law also separately restricts the distribution of human growth hormone for uses other than an authorised medical use under a doctor's order (21 U.S.C. 333(e)). Tressless does not state whether any particular product is lawful.

Tressless is not aware of any regulator having issued a warning or ban relating to sh-Polypeptide-7. Absence of a warning is not the same as a positive safety finding — it usually reflects that the ingredient has not been reviewed.

What This Adds Up To

There is no published evidence showing that sh-Polypeptide-7 causes harm, and no published evidence establishing that it is safe. Cosmetic peptides as a class are generally described as having low irritation and allergy potential, but sh-Polypeptide-7 is a recombinant hormone rather than a typical small cosmetic peptide, so that description may not apply to it.

Mild irritation is always possible in sensitive individuals, whether any of the hormone reaches the bloodstream has not been studied, no long-term human data exist for this ingredient, and no independent expert panel review of it has been published. Personal sensitivity varies, patch testing a new product remains a sensible precaution, and anyone with a scalp condition or a history of reactions should raise it with a doctor or dermatologist first.